Effect of fingolimod on quality of life in paediatric MS: Results of the phase 3 PARADIGMS study

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2018
This article has no abstract
Epistemonikos ID: 4df3a6ed8f845975b940383e17f75a9875dd4660
First added on: Apr 30, 2026